Key statistics dashboard for Senseonics Holdings, Inc. (SENS). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices.
Stock Data
| Price | $9.06 |
| Market Cap | $379M |
| Enterprise Value | $394.0M |
| Beta | 1.05 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -3.91 |
| Price / Book | 5.69 |
| P/S | 7.65 |
| EV/EBITDA | -3.85 |
| EV/Sales | 8.12 |
| EV/FCF | -4.07 |
| P/FCF | -3.83 |
| Earnings Yield | -20.97% |
| FCF Yield | -25.69% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 54.87% |
| EBIT Margin | -214.69% |
| EBITDA Margin | -210.88% |
| Operating Margin | -223.22% |
| Net Margin | -225.34% |
| Return on Equity | -165.83% |
| Return on Assets | -61.86% |
| Return on Invested Capital | -71.22% |
| Return on Capital Employed | -71.22% |
Financial Health
| Current Ratio | 6.74 |
| Quick Ratio | 6.40 |
| Cash Ratio | 1.81 |
| Debt / Equity | 0.68 |
| Debt / Assets | 34.97% |
| Net Debt / EBITDA | -0.17 |
| Interest Coverage | -20.96 |
Per-Share Data
| Revenue per share | 0.84 |
| Book Value per share | 1.56 |
| Cash per share | 2.47 |
| FCF per share | -1.67 |
| Tangible Book Value per share | 1.56 |
| Dividend per share | 0.00 |
Related companies: ACRS · CAPR · CERS · CVRX · MASS · NNOX · NPCE
Explore sector: Healthcare · Medical - Devices
More sections of SENS: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks